Evidence-Based Medicine Guidelines
Mirabegron for urinary incontinence and overactive bladder
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mirabegron for Urinary Incontinence and Overactive Bladder." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305334/all/Mirabegron_for_urinary_incontinence_and_overactive_bladder.
Mirabegron for urinary incontinence and overactive bladder. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305334/all/Mirabegron_for_urinary_incontinence_and_overactive_bladder. Accessed April 22, 2025.
Mirabegron for urinary incontinence and overactive bladder. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305334/all/Mirabegron_for_urinary_incontinence_and_overactive_bladder
Mirabegron for Urinary Incontinence and Overactive Bladder [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305334/all/Mirabegron_for_urinary_incontinence_and_overactive_bladder.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mirabegron for urinary incontinence and overactive bladder
ID - 1305334
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305334/all/Mirabegron_for_urinary_incontinence_and_overactive_bladder
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
